We are live on ! Find out more
AEMD icon

Aethlon Medical

6 hedge funds and large institutions have $1.98M invested in Aethlon Medical in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 76 (-1)

26% less capital invested

Capital invested by funds: $2.7M → $1.98M (-$715K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q1 2016 in Review

6 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2016, worth a combined $1.98M — down 26% from $2.7M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of AEMD and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Bank of New York Mellon, exiting entirely with an estimated $111K sold.

  • 6 institutional investors held Aethlon Medical (AEMD) as of Q1 2016, down from 7 in Q4 2015.
  • Funds reported $1.98M of Aethlon Medical stock for Q1 2016, down 26% quarter-over-quarter.
  • 1 fund opened new Aethlon Medical positions in Q1 2016 and 2 closed out, a net change of -1 holder.
  • The largest Aethlon Medical seller in Q1 2016 was Bank of New York Mellon, an estimated $111K sold.

Based on aggregated 13F filings for Q1 2016.